Quarterly EPS earnings growth: DexCom, Inc. (DXCM)
High motivation among R&D staff and the recruitment of top engineers support the momentum demonstrated by the quarterly EPS change. The 2.60 level reflects the state of the operational efficiency parameter. Growth is based on exclusive patents and strict FDA control, while the success of DexCom, Inc. (DXCM) relies on patient loyalty and access to health insurance programs.
%20Year-over-year%20net%20earnings%20per%20share%20growth%20for%20the%20last%2012%20months&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_DXCM_-_DexCom-Inc._-_Year-over-year-net-earnings-per-share-growth-for-the-last-12-months "dexcom.com (DXCM) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/10/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns for DexCom, Inc.
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- balance sheet net asset value indicators:
- debt and liquidity details:
- earnings and valuation multiples information:
DXCM - Net Profit|Expected Profit DexCom, Inc.|DXCM - Price to Earnings Ratio|Projected Price to Earnings Dexcom Corp|DXCM - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Dexcom Corp|DXCM - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Dexcom|DXCM - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months dexcom.com|DXCM - Earnings growth in current year|Earnings growth forecast for next year DexCom, Inc.
Summary company analysis:Dexcom - DXCM
Fundamental asset selection requires an analysis of net earnings per share dynamics. This indicator compares quarterly EPS growth with the daily closing price to identify abnormal stagnation. For DexCom, Inc. (DXCM), with its recurring sensor sales, such stability may signal that growth drivers have been exhausted. It is critical for investors to monitor the volatility of the quarterly EPS figure to timely detect the risk of opportunity cost.
Competitors of DexCom, Inc. (DXCM)
PEN: Quarterly EPS earnings growth|NOVT - Year-over-year net earnings per share change for the last twelve months|HAE (Haemonetics Corp.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Inspire Medical Systems Inc (INSP)|Year-over-year net earnings per share growth for the last 12 months PRCT (PROCEPT BioRobotics)|CNMD (conmed.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Pulse Biosciences PLSE|INMD - Year-over-year net earnings per share growth for the last 12 months|Picard Medical Inc. - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Surmodics Inc.|SENS: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months NPCE|TCMD (Tactile Systems Technology, Inc.) - Quarterly EPS earnings growth|SANUWAVE Health (SNWV) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth OM|Year-over-year net earnings per share growth for the last 12 months smartvest.com ELMD|Quarterly EPS earnings growth LNSR (LENSAR, Inc.)|Quarterly EPS earnings growth avitamedical.com RCEL|PROF - Year-over-year earnings per share growth for the last twelve months|BDMD: Year-over-year earnings per share growth for the last twelve months|EDAP (edap-tms.com) - Year-over-year net earnings per share growth for the last 12 months|Apyx Medical Corporation - Year-over-year earnings per one share growth for the last 12 months|ICCM (IceCure Medical Ltd.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Pulmonx Corp. LUNG|Year-over-year earnings per share growth for the last twelve months TELA Bio, Inc. (TELA)|cytosorbents.com (CTSO) - Net earnings per share growth for the trailing year|Sensus Healthcare Corp - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Zynex Corp ZYXI|electroCore Medical - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Vicarious Surgical Inc. RBOT|inspira-technologies.com (IINN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ICU (SeaStar Medical Holding Corporation)|Year-over-year earnings per share growth for the last twelve months IRIDEX Corp|Year-over-year net earnings per share growth for the last 12 months Intelligent Bio (INBS)|Quarterly EPS earnings growth XAIR|PFSA - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months STRATA Skin Sciences, Inc. SSKN|GCTK: Year-over-year earnings per share growth for the last 12 months|NAOV: Year-over-year net earnings per share growth for the last 12 months|Venus Concept Corporation - Year-over-year earnings per share growth rate for the last twelve months|NUWE: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months AEMD|ASXC (Asensus Surgical Inc) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Avinger Inc. AVGR|Year-over-year net earnings per share growth for the last 12 months BSGM (Biosig Technologies)|Cutera Inc - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNW (Know Labs, Inc.)|NARI - Year-over-year net earnings per share growth for the last 12 months|NVRO - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months ReShape Lifesciences|Silk Road Medical Inc. (SILK) - Year-over-year earnings per share growth for the last twelve months
